Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-7drxs Total loading time: 0 Render date: 2024-07-16T15:59:53.275Z Has data issue: false hasContentIssue false

22 - Future fertility insurance

from SECTION 5 - FUTURE FERTILITY INSURANCE: SCREENING, CRYOPRESERVATION OR EGG DONORS?

Published online by Cambridge University Press:  05 February 2014

Susan Bewley
Affiliation:
St Thomas’s Hospital, London
William Ledger
Affiliation:
University of New South Wales, Sydney
Dimitrios Nikolaou
Affiliation:
Chelsea and Westminster Hospital, London
Get access

Summary

William Ledger: Thanks very much for three very good talks. While the other speakers are returning, perhaps I could ask Professor Dickenson to comment as you have a professional and personal interest in this topic.

Donna Dickenson: Thank you very much. I have in fact written a book on this. I think the situation is actually even grimmer than Melanie portrayed it — and it is quite grim as she portrayed it. The American Society of Reproductive Medicine (ASRM) does set a maximum, or recommends there is a maximum, of US$5,000 but surveys indicate that currently only half of its members obey it. There have been substantiated reports of up to US$100,000. There have also been substantiated evidence-based reports of up to 70 eggs being taken in only one cycle. The other thing which is quite worrying is that although we say that it is an American phenomenon, even in America you cannot buy and sell organs. However, there is an ambivalence in the relevant 1987 Act, which actually makes an exception to the general principle, because gametes, as it puts it, are renewable tissue. So gametes are exempted. So, it is all based on a massive legislative mistake! It is worrying, as you quite rightly point out, that the trade is developing in Eastern Europe, Spain and Cyprus. There is very strong evidence, not just in the Observer report, but further reports since, of a massive element of trafficking also involved. So, I think the situation is bad. There are a few favourable signs such as the European Union directive barring the sale of eggs for IVF, but not for stem cell research.

Type
Chapter
Information
Reproductive Ageing , pp. 237 - 242
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×